Drug addiction: pathways to the disease and pathophysiological perspectives
- PMID: 17169534
- DOI: 10.1016/j.euroneuro.2006.10.006
Drug addiction: pathways to the disease and pathophysiological perspectives
Abstract
Drug addiction is a medical condition, a chronic relapsing disease. As in other domains of experimental medicine, appropriate experimental investigations are needed in order to better understand the disease. However, to understand the diverse facets of drug effects and of the underlying pathophysiology it is necessary to keep in mind the complexity of the psychopathological processes. The main symptoms that characterize addiction correspond to expressions of dysfunctions within specific circuits and regions. Pathways to addiction are numerous and comorbidity and in the real world poly-drug use are common. Some of these aspects will be examined as well as the role of life events and stress. Theoretical considerations will be proposed [see also: Koob, G.F., & Le Moal, M.. 2005a. Neurobiology of Addiction. Elsevier. 570 pp] to account for the stages of the disease from impulse control disorder to compulsive disorders, for affective dynamics and for the relations between the symptoms and pathophysiology.
Similar articles
-
[Current status in drug addiction and addiction memory research].Sheng Li Ke Xue Jin Zhan. 2003 Jul;34(3):202-6. Sheng Li Ke Xue Jin Zhan. 2003. PMID: 14628463 Review. Chinese.
-
Drug addiction: a general review of new concepts and future challenges.East Mediterr Health J. 2000 Jul;6(4):723-33. East Mediterr Health J. 2000. PMID: 11794078 Review.
-
Systems biology and addiction.Pharmacopsychiatry. 2009 May;42 Suppl 1:S11-31. doi: 10.1055/s-0029-1220699. Epub 2009 May 11. Pharmacopsychiatry. 2009. PMID: 19434548 Review.
-
Glutamatergic mechanisms in addiction.Mol Psychiatry. 2003 Apr;8(4):373-82. doi: 10.1038/sj.mp.4001269. Mol Psychiatry. 2003. PMID: 12740594 Review.
-
Drug abuse: vulnerability and transition to addiction.Pharmacopsychiatry. 2009 May;42 Suppl 1:S42-55. doi: 10.1055/s-0029-1216355. Epub 2009 May 11. Pharmacopsychiatry. 2009. PMID: 19434555 Review.
Cited by
-
The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?Br J Pharmacol. 2012 Aug;166(7):1993-2014. doi: 10.1111/j.1476-5381.2012.01952.x. Br J Pharmacol. 2012. PMID: 22428846 Free PMC article. Review.
-
Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system.Naunyn Schmiedebergs Arch Pharmacol. 2008 Oct;378(4):407-20. doi: 10.1007/s00210-008-0304-9. Epub 2008 Jun 12. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18548233
-
Effects of Vocational Consultation on Relapse Rate and Hope among Drug Dependents in Bojnurd, Iran.Electron Physician. 2016 Jan 15;8(1):1711-7. doi: 10.19082/1711. eCollection 2016 Jan. Electron Physician. 2016. PMID: 26955440 Free PMC article.
-
Clinical and Preclinical Evidence for Gut Microbiome Mechanisms in Substance Use Disorders.Biol Psychiatry. 2024 Feb 15;95(4):329-338. doi: 10.1016/j.biopsych.2023.08.004. Epub 2023 Aug 10. Biol Psychiatry. 2024. PMID: 37573004 Free PMC article. Review.
-
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.Br J Pharmacol. 2008 May;154(2):384-96. doi: 10.1038/bjp.2008.100. Epub 2008 Apr 14. Br J Pharmacol. 2008. PMID: 18414400 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous